Cervical Cancer Screening Among Hispanic Women

Cervical Cancer Screening and Adherence to Follow-up Among Hispanic Women

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01525433

Enrollment

451

Registered

2012-02-03

Start date

2011-09-30

Completion date

2018-07-17

Last updated

2018-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Brief summary

In this study, 400 Hispanic women will be recruited and randomized to one of three interventions: 1. Control (no change); 2. A low-intensity information program, consisting of a video approach educating women on the importance of cervical cancer screening; 3. A higher intensity program consisting of the video plus a 'promotora' or lay-community health educator led intervention at the participant's home to encourage cervical cancer screening. The investigators will compare which intervention is most effective in encouraging Hispanic women to undergo cervical cancer screening (Pap test)

Interventions

BEHAVIORALDVD

Participants will received a mailed DVD containing culturally appropriate information about the importance of cervical cancer screening

BEHAVIORALPromotora

Participants will receive a home visit from a lay community health educator ('Promotora') and will be shown a DVD containing culturally appropriate information to educate participants about the importance of cervical cancer screening

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

21 Years to 64 Years

Healthy volunteers

Yes

Inclusion criteria

* Female * 21 - 64 years of age * Hispanic or Latina * Resident of the Yakima Valley, WA, USA * No hysterectomy * Last PAP test (cervical screening) more than 3 years ago * Last seen at the local clinic less than 5 years ago

Exclusion criteria

* Less than 21 or greater than 64 years of age * PAP test less 3 years ago * Prior hysterectomy

Design outcomes

Primary

Measure	Time frame
Participant attends cervical cancer screening	Within 7 months of the intervention

Secondary

Measure	Time frame	Description
Patient Navigator	Elapsed time from diagnosis to clinic visit	Evaluation of the patient navigator program as a method to improve adherence and reduce time to follow-up among study participants who receive an abnormal Pap test result. Time to follow-up will be compared to a similar population of patients who were not part of the study who also receive a diagnosis of an abnormal Pap test.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026